menu
    • menu
    [{"orgOrder":0,"company":"Orphelia Pharma","sponsor":"Ethypharm","pharmaFlowCategory":"D","therapeuticArea":"Neurology","country":"","productType":"Small molecule","year":"2021","type":"Licensing Agreement","leadProduct":"Vigabatrin","moa":"","graph1":"Technology","graph2":"Phase I\/II","graph3":"Orphelia Pharma","amount2":0,"highestDevelopmentShortName":"","therapeuticAreaShortName":"Technology","amount2New":0.94999999999999996,"dosageForm":"","sponsorNew":"Orphelia Pharma \/ Ethypharm","highestDevelopmentStatusID":"14","companyTruncated":"Orphelia Pharma \/ Ethypharm"}]

    Find Clinical Drug Pipeline Developments & Deals by Orphelia Pharma

    Menu

    Orphelia Pharma

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Orphelia Pharma

                            France arrow
                            BioFlorida Conference
                            Not Confirmed

                            Orphelia Pharma

                            France arrow
                            BioFlorida Conference
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Vigabatrin

                            Therapeutic Area : Neurology

                            Study Phase : Approved

                            Sponsor : Ethypharm

                            Deal Size : Undisclosed

                            Deal Type : Licensing Agreement

                            DEALS_DEV arrow-down

                            ORPHELIA, Ethypharm Sign Kigabeq® Licensing Deal for China

                            Details : Orphelia has granted Ethypharm exclusive rights under a license agreement to commercialize Kigabeq (vigabatrin) in China. Kigabeq is indicated as a first-line treatment for infantile spasms.

                            Brand Name : Kigabeq

                            Molecule Type : Small molecule

                            Upfront Cash : Undisclosed

                            January 19, 2021

                            Lead Product(s) : Vigabatrin

                            Therapeutic Area : Neurology

                            Highest Development Status : Approved

                            Sponsor : Ethypharm

                            Deal Size : Undisclosed

                            Deal Type : Licensing Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth